This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival | MicrobiomeTrials
← Back to trials NCT06256354
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-05-29Est. Completion: 2029-06
Enrollment target: 3,992 participantsLocations The People's Hospital of Chizhou, Chizhou, Anhui, China The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China Maanshan People's Hospital, Ma’anshan, Anhui, China Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing, Beijing Municipality, China Peking University First Hospital, Beijing, Beijing Municipality, China Guang'anmen Hospital China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China Peking Union Medical College Hospital, Beijing, Beijing Municipality, China Aerospace Medical Center, Beijing, Beijing Municipality, China Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing Municipality, China Beijing Chuiyangliu Hospital, Beijing, Beijing Municipality, China Beijing Coal Group General Hospital, Beijing, Beijing Municipality, China Beijing Electric Power Hospital, Beijing, Beijing Municipality, China Other microbiome trials you might be interested in Prostate Cancer
The purpose of this research is to gather information on the safety and effectiveness of combining focal prostate ablati…
Chicago, United States Est. completion Dec 18, 2028
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
The purpose of this phase Ib/II study is to (a) in Phase Ib evaluate the safety, tolerability, and pharmacokinetics (PK)…
El Paso, United States Est. completion Jul 10, 2028
Peking University International Hospital, Beijing, Beijing Municipality, China
The First Hospital of Tsinghua University, Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital), Shijiazhuang, Hebei, China
First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Jingzhou Central Hospital, Jingzhou, Hubei, China
Jiangyin People's Hospital, Jiangyin, Jiangsu, China
The First Affiliated Hospital of Kangda College of Nanjing Medical University ( Lianyungang First People's Hospital), Lianyungang, Jiangsu, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
The People's Hospital of Wuxi, Wuxi, Jiangsu, China
Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China
The People's Hospital of Liaocheng, Liaocheng, Shandong, China
Chengdu Seventh People's Hospital, Chengdu, Sichuan, China
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China
The Second People's Hospital of Yibin (affiliated with West China Hospital of Sichuan University), Chengdu, Sichuan, China
Deyang People's Hospital, Deyang, Sichuan, China Prostate Cancer (Post Prostatectomy) Radiotherapy; Image-Guided Prostate Cancer Non-Metastatic Androgen Deprivation Therapy Lymph Node Positive
The goal of this clinical trial is to evaluate whether the addition of pelvic radiotherapy to androgen deprivation thera…
Dongguan, China Est. completion Dec 31, 2033